

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 7.48559894 |
| 2 | sulfate transmembrane transport (GO:1902358) | 6.87700606 |
| 3 | intestinal cholesterol absorption (GO:0030299) | 6.48264078 |
| 4 | regulation of autophagic vacuole assembly (GO:2000785) | 6.38356140 |
| 5 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 6.36327434 |
| 6 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 6.36327434 |
| 7 | NADH metabolic process (GO:0006734) | 6.33315314 |
| 8 | negative regulation of macroautophagy (GO:0016242) | 6.22947827 |
| 9 | cytidine metabolic process (GO:0046087) | 5.89472664 |
| 10 | cytidine catabolic process (GO:0006216) | 5.89472664 |
| 11 | cytidine deamination (GO:0009972) | 5.89472664 |
| 12 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.87244143 |
| 13 | bile acid and bile salt transport (GO:0015721) | 5.76658080 |
| 14 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.70696551 |
| 15 | sulfate transport (GO:0008272) | 5.68473632 |
| 16 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.58777349 |
| 17 | angiotensin maturation (GO:0002003) | 5.57627811 |
| 18 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 5.48101813 |
| 19 | epoxygenase P450 pathway (GO:0019373) | 5.22484732 |
| 20 | protein neddylation (GO:0045116) | 5.13479173 |
| 21 | regulation of vacuole organization (GO:0044088) | 5.05687925 |
| 22 | regulation of vitamin metabolic process (GO:0030656) | 5.01870239 |
| 23 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.96176335 |
| 24 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.80492409 |
| 25 | positive regulation of pseudopodium assembly (GO:0031274) | 4.79024102 |
| 26 | negative regulation of organelle assembly (GO:1902116) | 4.66815488 |
| 27 | regulation of cellular extravasation (GO:0002691) | 4.65011513 |
| 28 | actin filament depolymerization (GO:0030042) | 4.63486613 |
| 29 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.62824458 |
| 30 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.62824458 |
| 31 | endocrine process (GO:0050886) | 4.62824458 |
| 32 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.61596344 |
| 33 | intestinal epithelial cell development (GO:0060576) | 4.59887075 |
| 34 | sulfur compound transport (GO:0072348) | 4.57984602 |
| 35 | regulation of viral release from host cell (GO:1902186) | 4.53953732 |
| 36 | flavonoid metabolic process (GO:0009812) | 4.51355444 |
| 37 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.51325442 |
| 38 | fructose metabolic process (GO:0006000) | 4.47461208 |
| 39 | urea cycle (GO:0000050) | 4.47265925 |
| 40 | positive regulation of T cell differentiation in thymus (GO:0033089) | 4.38919983 |
| 41 | regulation of systemic arterial blood pressure (GO:0003073) | 4.32828944 |
| 42 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.32479981 |
| 43 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.31312308 |
| 44 | epithelial structure maintenance (GO:0010669) | 4.30375130 |
| 45 | renal system process involved in regulation of blood volume (GO:0001977) | 4.29669076 |
| 46 | O-glycan processing (GO:0016266) | 4.28972602 |
| 47 | digestive system process (GO:0022600) | 4.28328745 |
| 48 | lipoprotein transport (GO:0042953) | 4.27896293 |
| 49 | regulation of pseudopodium assembly (GO:0031272) | 4.26251843 |
| 50 | vitamin A metabolic process (GO:0006776) | 4.25926497 |
| 51 | positive regulation of respiratory burst (GO:0060267) | 4.24855113 |
| 52 | alkaloid metabolic process (GO:0009820) | 4.24128759 |
| 53 | keratinocyte development (GO:0003334) | 4.23436503 |
| 54 | urea metabolic process (GO:0019627) | 4.20370139 |
| 55 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 4.19644134 |
| 56 | chondrocyte proliferation (GO:0035988) | 4.13275801 |
| 57 | renal filtration (GO:0097205) | 4.11399016 |
| 58 | cellular glucuronidation (GO:0052695) | 4.09550969 |
| 59 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.09261097 |
| 60 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.09045059 |
| 61 | response to hepatocyte growth factor (GO:0035728) | 4.09045059 |
| 62 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.07351991 |
| 63 | glomerular filtration (GO:0003094) | 4.07169336 |
| 64 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.05942043 |
| 65 | drug metabolic process (GO:0017144) | 4.02384363 |
| 66 | uronic acid metabolic process (GO:0006063) | 4.02000416 |
| 67 | glucuronate metabolic process (GO:0019585) | 4.02000416 |
| 68 | regulation of cGMP biosynthetic process (GO:0030826) | 4.01612598 |
| 69 | epithelial cell-cell adhesion (GO:0090136) | 4.01114473 |
| 70 | sulfur amino acid catabolic process (GO:0000098) | 3.99113765 |
| 71 | hemidesmosome assembly (GO:0031581) | 3.97466487 |
| 72 | vitamin transmembrane transport (GO:0035461) | 3.92311494 |
| 73 | diacylglycerol metabolic process (GO:0046339) | 3.87291180 |
| 74 | hepatocyte apoptotic process (GO:0097284) | 3.82937013 |
| 75 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.81666821 |
| 76 | nitrogen cycle metabolic process (GO:0071941) | 3.81099833 |
| 77 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76250096 |
| 78 | desmosome organization (GO:0002934) | 3.70092353 |
| 79 | regulation of cholesterol homeostasis (GO:2000188) | 3.68097316 |
| 80 | drug catabolic process (GO:0042737) | 3.65302010 |
| 81 | adhesion of symbiont to host cell (GO:0044650) | 3.63380795 |
| 82 | virion attachment to host cell (GO:0019062) | 3.63380795 |
| 83 | GDP-mannose metabolic process (GO:0019673) | 3.59984285 |
| 84 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.59551140 |
| 85 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.59551140 |
| 86 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.59551140 |
| 87 | auditory receptor cell differentiation (GO:0042491) | 3.53962655 |
| 88 | peptide hormone processing (GO:0016486) | 3.53723768 |
| 89 | positive regulation of epidermis development (GO:0045684) | 3.50983711 |
| 90 | regulation of keratinocyte proliferation (GO:0010837) | 3.50870968 |
| 91 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.48547443 |
| 92 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.37755338 |
| 93 | oligosaccharide biosynthetic process (GO:0009312) | 3.37643510 |
| 94 | sulfation (GO:0051923) | 3.36821839 |
| 95 | regulation of respiratory burst (GO:0060263) | 3.32308798 |
| 96 | glycosphingolipid catabolic process (GO:0046479) | 3.30645834 |
| 97 | regulation of water loss via skin (GO:0033561) | 3.30413379 |
| 98 | ethanol oxidation (GO:0006069) | 3.30374736 |
| 99 | glycolipid catabolic process (GO:0019377) | 3.29619530 |
| 100 | vitamin transport (GO:0051180) | 3.29261321 |
| 101 | regulation of cGMP metabolic process (GO:0030823) | 3.29195036 |
| 102 | homocysteine metabolic process (GO:0050667) | 3.28207647 |
| 103 | bicarbonate transport (GO:0015701) | 3.28199665 |
| 104 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.26599817 |
| 105 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.25539047 |
| 106 | modified amino acid transport (GO:0072337) | 3.22911223 |
| 107 | renal absorption (GO:0070293) | 3.22523281 |
| 108 | drug transmembrane transport (GO:0006855) | 3.17808873 |
| 109 | negative regulation of receptor activity (GO:2000272) | 3.17032676 |
| 110 | glucose 6-phosphate metabolic process (GO:0051156) | 3.16575836 |
| 111 | sphingomyelin metabolic process (GO:0006684) | 3.16405442 |
| 112 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.16297012 |
| 113 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.15898477 |
| 114 | digestion (GO:0007586) | 3.15834059 |
| 115 | arginine metabolic process (GO:0006525) | 3.08584199 |
| 116 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.06968488 |
| 117 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.06968488 |
| 118 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.06968488 |
| 119 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.06727166 |
| 120 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.03685379 |
| 121 | multicellular organismal water homeostasis (GO:0050891) | 3.03608595 |
| 122 | antibacterial humoral response (GO:0019731) | 3.03518088 |
| 123 | transcytosis (GO:0045056) | 3.01892817 |
| 124 | antimicrobial humoral response (GO:0019730) | 3.01063630 |
| 125 | establishment of skin barrier (GO:0061436) | 2.98843946 |
| 126 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.98495829 |
| 127 | striated muscle atrophy (GO:0014891) | 2.97686670 |
| 128 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.96239897 |
| 129 | thrombin receptor signaling pathway (GO:0070493) | 2.95832943 |
| 130 | ethanol metabolic process (GO:0006067) | 2.95439491 |
| 131 | citrulline biosynthetic process (GO:0019240) | 2.94415878 |
| 132 | plasma lipoprotein particle assembly (GO:0034377) | 2.93931345 |
| 133 | nucleotide salvage (GO:0043173) | 2.93910138 |
| 134 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.93619960 |
| 135 | positive regulation of lipid catabolic process (GO:0050996) | 2.92523326 |
| 136 | drug transport (GO:0015893) | 2.92005847 |
| 137 | bone resorption (GO:0045453) | 2.91792378 |
| 138 | somite development (GO:0061053) | 2.91145819 |
| 139 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.91090878 |
| 140 | proline biosynthetic process (GO:0006561) | 2.89738259 |
| 141 | neurotransmitter biosynthetic process (GO:0042136) | 2.88810637 |
| 142 | cellular response to nitric oxide (GO:0071732) | 2.87660908 |
| 143 | cGMP-mediated signaling (GO:0019934) | 2.86906192 |
| 144 | thyroid hormone metabolic process (GO:0042403) | 2.86828125 |
| 145 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.86813153 |
| 146 | primary alcohol catabolic process (GO:0034310) | 2.86687406 |
| 147 | regulation of cholesterol metabolic process (GO:0090181) | 2.85360737 |
| 148 | cyclooxygenase pathway (GO:0019371) | 2.84915852 |
| 149 | regulation of triglyceride catabolic process (GO:0010896) | 2.83464059 |
| 150 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.83267749 |
| 151 | adhesion of symbiont to host (GO:0044406) | 2.82938373 |
| 152 | phospholipid homeostasis (GO:0055091) | 2.82805023 |
| 153 | regulation of guanylate cyclase activity (GO:0031282) | 2.81626792 |
| 154 | phospholipid scrambling (GO:0017121) | 2.81099851 |
| 155 | peptide catabolic process (GO:0043171) | 2.77106504 |
| 156 | lipoprotein metabolic process (GO:0042157) | 2.75650464 |
| 157 | cholesterol homeostasis (GO:0042632) | 2.74090760 |
| 158 | sterol homeostasis (GO:0055092) | 2.72218020 |
| 159 | phospholipid efflux (GO:0033700) | 2.71712127 |
| 160 | response to hydroperoxide (GO:0033194) | 2.71659464 |
| 161 | hormone catabolic process (GO:0042447) | 2.71017090 |
| 162 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.70529393 |
| 163 | sperm capacitation (GO:0048240) | 2.66163763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.94815051 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.63783605 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.47480749 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.88752005 |
| 5 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.78976374 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.77935722 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.72098603 |
| 8 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.65055614 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.56829817 |
| 10 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.46732592 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44873531 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.41618431 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.39074057 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37459518 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.32178477 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27394209 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.19625951 |
| 18 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.94774813 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.93410507 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.87871502 |
| 21 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.81059578 |
| 22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.77805834 |
| 23 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.76944970 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73263764 |
| 25 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.72786634 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.72363676 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70615317 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70610246 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70585053 |
| 30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.66589710 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65314560 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.65119417 |
| 33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62811025 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.61449660 |
| 35 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60968431 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56286883 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55394580 |
| 38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52874303 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52525290 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52254385 |
| 41 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.50830228 |
| 42 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.49440260 |
| 43 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.49315338 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.46056711 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.45566392 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45556206 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40477222 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40186123 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37380280 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37233039 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36027039 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34114099 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29404547 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28110534 |
| 55 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27710355 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27210479 |
| 57 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26942409 |
| 58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26249096 |
| 59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25467762 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.25227653 |
| 61 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24440834 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19962890 |
| 63 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18977549 |
| 64 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18977549 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.18102303 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16055647 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15208759 |
| 68 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14354404 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14281427 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13667679 |
| 71 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.13474020 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12860222 |
| 73 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.12273489 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10583027 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10361374 |
| 76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10214169 |
| 77 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10159602 |
| 78 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09985991 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08173483 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.07960479 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07792536 |
| 82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05517122 |
| 83 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.05045166 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04615467 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03858078 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03636634 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02389412 |
| 88 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01875542 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01499627 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01145349 |
| 91 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01043707 |
| 92 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00818297 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00461636 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00087036 |
| 95 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99948167 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99769779 |
| 97 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99332672 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98493022 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97600956 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96546886 |
| 101 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96361060 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94726963 |
| 103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94446453 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94192764 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93241277 |
| 106 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92609933 |
| 107 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91150640 |
| 108 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.89943695 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88930453 |
| 110 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88043022 |
| 111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87629329 |
| 112 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.87326359 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.85853489 |
| 114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85521067 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84926962 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84295721 |
| 117 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83981900 |
| 118 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83624873 |
| 119 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83507253 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83214949 |
| 121 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.79594823 |
| 122 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.77599742 |
| 123 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77531303 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75970762 |
| 125 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75144863 |
| 126 | P68_20966046_ChIP-Seq_HELA_Human | 0.73754102 |
| 127 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.72508126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 8.55242710 |
| 2 | MP0003283_abnormal_digestive_organ | 5.66996715 |
| 3 | MP0005360_urolithiasis | 5.26067166 |
| 4 | MP0001666_abnormal_nutrient_absorption | 4.62064143 |
| 5 | MP0000462_abnormal_digestive_system | 3.79891772 |
| 6 | MP0004264_abnormal_extraembryonic_tissu | 3.57438234 |
| 7 | MP0003866_abnormal_defecation | 3.13305751 |
| 8 | MP0003315_abnormal_perineum_morphology | 2.77364548 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.64624684 |
| 10 | MP0009053_abnormal_anal_canal | 2.60342308 |
| 11 | MP0002234_abnormal_pharynx_morphology | 2.51547809 |
| 12 | MP0005409_darkened_coat_color | 2.41738757 |
| 13 | MP0000537_abnormal_urethra_morphology | 2.36566278 |
| 14 | MP0005381_digestive/alimentary_phenotyp | 2.15857485 |
| 15 | MP0003252_abnormal_bile_duct | 2.15697490 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.11165986 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.03959291 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.03343112 |
| 19 | MP0001663_abnormal_digestive_system | 2.02468026 |
| 20 | MP0000477_abnormal_intestine_morphology | 2.02118277 |
| 21 | MP0001873_stomach_inflammation | 2.01633169 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 1.98006858 |
| 23 | MP0003878_abnormal_ear_physiology | 1.94242603 |
| 24 | MP0005377_hearing/vestibular/ear_phenot | 1.94242603 |
| 25 | MP0010678_abnormal_skin_adnexa | 1.90553003 |
| 26 | MP0002822_catalepsy | 1.86945395 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 1.78637757 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.77678953 |
| 29 | MP0001664_abnormal_digestion | 1.74308614 |
| 30 | MP0000490_abnormal_crypts_of | 1.72403049 |
| 31 | MP0000566_synostosis | 1.70674301 |
| 32 | MP0002796_impaired_skin_barrier | 1.67490111 |
| 33 | MP0000538_abnormal_urinary_bladder | 1.65993658 |
| 34 | MP0004858_abnormal_nervous_system | 1.59885327 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.55423306 |
| 36 | MP0005365_abnormal_bile_salt | 1.54940544 |
| 37 | MP0004043_abnormal_pH_regulation | 1.54014326 |
| 38 | MP0009840_abnormal_foam_cell | 1.53717865 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.53543970 |
| 40 | MP0002098_abnormal_vibrissa_morphology | 1.53159980 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.46915218 |
| 42 | MP0001765_abnormal_ion_homeostasis | 1.40879950 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.39248772 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.38996486 |
| 45 | MP0002254_reproductive_system_inflammat | 1.35604287 |
| 46 | MP0006054_spinal_hemorrhage | 1.33701128 |
| 47 | MP0005670_abnormal_white_adipose | 1.29963450 |
| 48 | MP0004947_skin_inflammation | 1.29812549 |
| 49 | MP0008004_abnormal_stomach_pH | 1.28935669 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.28094633 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.28048191 |
| 52 | MP0001849_ear_inflammation | 1.21416332 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.20864760 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.17489111 |
| 55 | MP0000613_abnormal_salivary_gland | 1.10909822 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 1.08132120 |
| 57 | MP0003045_fibrosis | 1.08003553 |
| 58 | MP0001188_hyperpigmentation | 1.05965109 |
| 59 | MP0000467_abnormal_esophagus_morphology | 1.04098486 |
| 60 | MP0005310_abnormal_salivary_gland | 1.03877380 |
| 61 | MP0001756_abnormal_urination | 1.02575465 |
| 62 | MP0001764_abnormal_homeostasis | 0.99254913 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 0.96104220 |
| 64 | MP0000762_abnormal_tongue_morphology | 0.93935301 |
| 65 | MP0003868_abnormal_feces_composition | 0.93419781 |
| 66 | MP0005451_abnormal_body_composition | 0.93111495 |
| 67 | MP0005501_abnormal_skin_physiology | 0.91770998 |
| 68 | MP0001216_abnormal_epidermal_layer | 0.90736502 |
| 69 | MP0000470_abnormal_stomach_morphology | 0.90224166 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.87325327 |
| 71 | MP0002166_altered_tumor_susceptibility | 0.83836864 |
| 72 | MP0000377_abnormal_hair_follicle | 0.80652282 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.80286158 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.80008224 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.75762068 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.75526827 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75042972 |
| 78 | MP0003718_maternal_effect | 0.74147115 |
| 79 | MP0005023_abnormal_wound_healing | 0.71728641 |
| 80 | MP0008260_abnormal_autophagy | 0.71125636 |
| 81 | MP0004147_increased_porphyrin_level | 0.70443500 |
| 82 | MP0008872_abnormal_physiological_respon | 0.69693189 |
| 83 | MP0005166_decreased_susceptibility_to | 0.69490683 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.69318893 |
| 85 | MP0001881_abnormal_mammary_gland | 0.68131227 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.67701654 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.66739844 |
| 88 | MP0003329_amyloid_beta_deposits | 0.66599946 |
| 89 | MP0000516_abnormal_urinary_system | 0.66517791 |
| 90 | MP0005367_renal/urinary_system_phenotyp | 0.66517791 |
| 91 | MP0002971_abnormal_brown_adipose | 0.66074586 |
| 92 | MP0005165_increased_susceptibility_to | 0.65632749 |
| 93 | MP0005332_abnormal_amino_acid | 0.65381882 |
| 94 | MP0009379_abnormal_foot_pigmentation | 0.64311491 |
| 95 | MP0005448_abnormal_energy_balance | 0.64127054 |
| 96 | MP0004270_analgesia | 0.63933581 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 0.63492986 |
| 98 | MP0004272_abnormal_basement_membrane | 0.63122892 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.62647641 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.59749483 |
| 101 | MP0002277_abnormal_respiratory_mucosa | 0.59385192 |
| 102 | MP0002006_tumorigenesis | 0.58230558 |
| 103 | MP0000627_abnormal_mammary_gland | 0.57328855 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.54581795 |
| 105 | MP0000249_abnormal_blood_vessel | 0.54574455 |
| 106 | MP0003693_abnormal_embryo_hatching | 0.54335973 |
| 107 | MP0009115_abnormal_fat_cell | 0.54292497 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.54254260 |
| 109 | MP0003385_abnormal_body_wall | 0.52779376 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 0.52357721 |
| 111 | MP0000609_abnormal_liver_physiology | 0.52176245 |
| 112 | MP0000678_abnormal_parathyroid_gland | 0.51703546 |
| 113 | MP0003879_abnormal_hair_cell | 0.51206053 |
| 114 | MP0003937_abnormal_limbs/digits/tail_de | 0.50459501 |
| 115 | MP0002060_abnormal_skin_morphology | 0.50328525 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.49726668 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.49553753 |
| 118 | MP0001191_abnormal_skin_condition | 0.45783695 |
| 119 | MP0000163_abnormal_cartilage_morphology | 0.44816873 |
| 120 | MP0001501_abnormal_sleep_pattern | 0.44117327 |
| 121 | MP0000383_abnormal_hair_follicle | 0.42249384 |
| 122 | MP0005187_abnormal_penis_morphology | 0.42237461 |
| 123 | MP0002138_abnormal_hepatobiliary_system | 0.41794191 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.39449385 |
| 125 | MP0004185_abnormal_adipocyte_glucose | 0.39350444 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.39259986 |
| 127 | MP0009931_abnormal_skin_appearance | 0.38818381 |
| 128 | MP0010771_integument_phenotype | 0.38521934 |
| 129 | MP0000579_abnormal_nail_morphology | 0.38389396 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.38156973 |
| 131 | MP0002233_abnormal_nose_morphology | 0.37423177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Flat acetabular roof (HP:0003180) | 6.27338139 |
| 2 | Posterior subcapsular cataract (HP:0007787) | 6.17533861 |
| 3 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 5.23392563 |
| 4 | Ileus (HP:0002595) | 5.15257778 |
| 5 | Neonatal short-limb short stature (HP:0008921) | 5.11602447 |
| 6 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 5.01417865 |
| 7 | Cupped ribs (HP:0000887) | 5.00118467 |
| 8 | Abnormality of the 1st metacarpal (HP:0010009) | 4.84783954 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.84199097 |
| 10 | Flat capital femoral epiphysis (HP:0003370) | 4.47940968 |
| 11 | Decreased circulating renin level (HP:0003351) | 4.23238582 |
| 12 | Abdominal distention (HP:0003270) | 4.04519551 |
| 13 | Flattened epiphyses (HP:0003071) | 4.00909798 |
| 14 | Fragile nails (HP:0001808) | 3.99790299 |
| 15 | Abnormality of carpal bone ossification (HP:0006257) | 3.90593301 |
| 16 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.78489865 |
| 17 | Widely patent fontanelles and sutures (HP:0004492) | 3.74475500 |
| 18 | Spinal cord compression (HP:0002176) | 3.70750899 |
| 19 | Subcapsular cataract (HP:0000523) | 3.70544139 |
| 20 | Alkalosis (HP:0001948) | 3.67788150 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.64089967 |
| 22 | Irregular epiphyses (HP:0010582) | 3.62678411 |
| 23 | Breech presentation (HP:0001623) | 3.56053921 |
| 24 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 3.55270960 |
| 25 | Abnormality of vitamin B metabolism (HP:0004340) | 3.55013282 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 3.50981348 |
| 27 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.50931548 |
| 28 | Abnormal tarsal ossification (HP:0008369) | 3.45046117 |
| 29 | Thin bony cortex (HP:0002753) | 3.44269643 |
| 30 | Vertebral clefting (HP:0008428) | 3.42942090 |
| 31 | Vertebral hypoplasia (HP:0008417) | 3.41571910 |
| 32 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.41571910 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.39709275 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.36698524 |
| 35 | Short middle phalanx of finger (HP:0005819) | 3.36326838 |
| 36 | Abnormal cartilage morphology (HP:0002763) | 3.33153821 |
| 37 | Short phalanx of the thumb (HP:0009660) | 3.32895264 |
| 38 | Hemorrhage of the eye (HP:0011885) | 3.30328674 |
| 39 | Confusion (HP:0001289) | 3.28896769 |
| 40 | Woolly hair (HP:0002224) | 3.21707579 |
| 41 | Abnormal vertebral ossification (HP:0100569) | 3.16256917 |
| 42 | Abnormality of the 2nd finger (HP:0004100) | 3.14809384 |
| 43 | Abnormal hair laboratory examination (HP:0003328) | 3.13667043 |
| 44 | Large earlobe (HP:0009748) | 3.08568130 |
| 45 | Abnormality of vitamin metabolism (HP:0100508) | 3.07182630 |
| 46 | Focal segmental glomerulosclerosis (HP:0000097) | 3.06826889 |
| 47 | Congenital sensorineural hearing impairment (HP:0008527) | 3.00731543 |
| 48 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.97880688 |
| 49 | Malnutrition (HP:0004395) | 2.97047775 |
| 50 | Hyperparathyroidism (HP:0000843) | 2.94233978 |
| 51 | Abnormal hand bone ossification (HP:0010660) | 2.92620357 |
| 52 | Abnormal ossification of hand bones (HP:0005921) | 2.92318163 |
| 53 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.90590639 |
| 54 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.87346823 |
| 55 | Abnormality of chloride homeostasis (HP:0011422) | 2.85183977 |
| 56 | Pigmentary retinal degeneration (HP:0001146) | 2.84505415 |
| 57 | Wide cranial sutures (HP:0010537) | 2.83896722 |
| 58 | Conjugated hyperbilirubinemia (HP:0002908) | 2.83133739 |
| 59 | Metabolic alkalosis (HP:0200114) | 2.79890465 |
| 60 | Pili torti (HP:0003777) | 2.75850091 |
| 61 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.70471514 |
| 62 | Hoarse voice (HP:0001609) | 2.68169344 |
| 63 | Pustule (HP:0200039) | 2.60598755 |
| 64 | Hyperuricemia (HP:0002149) | 2.60223963 |
| 65 | Increased purine levels (HP:0004368) | 2.60223963 |
| 66 | Hypoplastic ilia (HP:0000946) | 2.60101533 |
| 67 | Chronic diarrhea (HP:0002028) | 2.59965763 |
| 68 | Visceral angiomatosis (HP:0100761) | 2.57879298 |
| 69 | Alopecia of scalp (HP:0002293) | 2.57674080 |
| 70 | Hyperglycinuria (HP:0003108) | 2.57290827 |
| 71 | Absent phalangeal crease (HP:0006109) | 2.57264087 |
| 72 | Ridged nail (HP:0001807) | 2.56998393 |
| 73 | Tracheal stenosis (HP:0002777) | 2.55807631 |
| 74 | Biliary tract neoplasm (HP:0100574) | 2.55464497 |
| 75 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.55419713 |
| 76 | Nephrolithiasis (HP:0000787) | 2.53957571 |
| 77 | Xanthomatosis (HP:0000991) | 2.52780967 |
| 78 | Hyperammonemia (HP:0001987) | 2.52071975 |
| 79 | Glomerulosclerosis (HP:0000096) | 2.51197335 |
| 80 | Milia (HP:0001056) | 2.50802221 |
| 81 | Proximal tubulopathy (HP:0000114) | 2.50135697 |
| 82 | Cone-rod dystrophy (HP:0000548) | 2.49993415 |
| 83 | Short hallux (HP:0010109) | 2.48911131 |
| 84 | Hypotension (HP:0002615) | 2.46887113 |
| 85 | Abnormal foot bone ossification (HP:0010675) | 2.46579392 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.46047014 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 2.46047014 |
| 88 | Breast hypoplasia (HP:0003187) | 2.45051899 |
| 89 | Pterygium (HP:0001059) | 2.43010294 |
| 90 | Nausea (HP:0002018) | 2.42031964 |
| 91 | Hypophosphatemia (HP:0002148) | 2.39492019 |
| 92 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 2.36955982 |
| 93 | Dehydration (HP:0001944) | 2.35294752 |
| 94 | Hyperphosphatemia (HP:0002905) | 2.32215592 |
| 95 | Hemangiomatosis (HP:0007461) | 2.31648437 |
| 96 | Hyperaldosteronism (HP:0000859) | 2.31277164 |
| 97 | Acanthocytosis (HP:0001927) | 2.30983202 |
| 98 | Abnormal biliary tract morphology (HP:0012440) | 2.30477089 |
| 99 | Micronodular cirrhosis (HP:0001413) | 2.28927328 |
| 100 | Villous atrophy (HP:0011473) | 2.27957775 |
| 101 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.27957775 |
| 102 | Hip contracture (HP:0003273) | 2.27827972 |
| 103 | Lumbar hyperlordosis (HP:0002938) | 2.26486696 |
| 104 | Onycholysis (HP:0001806) | 2.24666238 |
| 105 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.24164185 |
| 106 | Renal tubular acidosis (HP:0001947) | 2.23995103 |
| 107 | Growth hormone excess (HP:0000845) | 2.23866833 |
| 108 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22962281 |
| 109 | Proximal placement of thumb (HP:0009623) | 2.22449350 |
| 110 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.20883591 |
| 111 | Progressive sensorineural hearing impairment (HP:0000408) | 2.19886608 |
| 112 | Shawl scrotum (HP:0000049) | 2.19537070 |
| 113 | Hyperphosphaturia (HP:0003109) | 2.17768951 |
| 114 | Coronal craniosynostosis (HP:0004440) | 2.17065467 |
| 115 | Hypobetalipoproteinemia (HP:0003563) | 2.17010663 |
| 116 | Curly hair (HP:0002212) | 2.16881100 |
| 117 | Atrophic scars (HP:0001075) | 2.16119558 |
| 118 | Gout (HP:0001997) | 2.15511004 |
| 119 | Abnormality of glycine metabolism (HP:0010895) | 2.13648837 |
| 120 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.13648837 |
| 121 | Abnormality of purine metabolism (HP:0004352) | 2.12994707 |
| 122 | Deviation of the thumb (HP:0009603) | 2.12043538 |
| 123 | Fat malabsorption (HP:0002630) | 2.10894239 |
| 124 | Polar cataract (HP:0010696) | 2.09946333 |
| 125 | Abnormal finger flexion creases (HP:0006143) | 2.09063283 |
| 126 | Steatorrhea (HP:0002570) | 2.07763666 |
| 127 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04298482 |
| 128 | Delayed epiphyseal ossification (HP:0002663) | 2.03611107 |
| 129 | Abnormality of femoral epiphyses (HP:0006499) | 2.02183654 |
| 130 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.02183654 |
| 131 | Abnormality of urine glucose concentration (HP:0011016) | 2.01144695 |
| 132 | Glycosuria (HP:0003076) | 2.01144695 |
| 133 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01013391 |
| 134 | Protuberant abdomen (HP:0001538) | 2.00884137 |
| 135 | Late onset (HP:0003584) | 2.00519882 |
| 136 | Abnormal glucose tolerance (HP:0001952) | 2.00502424 |
| 137 | Intrahepatic cholestasis (HP:0001406) | 2.00206270 |
| 138 | Hip dysplasia (HP:0001385) | 2.00007082 |
| 139 | Short tibia (HP:0005736) | 1.98473020 |
| 140 | Short humerus (HP:0005792) | 1.98470590 |
| 141 | Enlarged epiphyses (HP:0010580) | 1.98172225 |
| 142 | Abnormality of the middle phalanges of the hand (HP:0009833) | 1.97940765 |
| 143 | Megaloblastic anemia (HP:0001889) | 1.97485413 |
| 144 | Plantar hyperkeratosis (HP:0007556) | 1.97056591 |
| 145 | Down-sloping shoulders (HP:0200021) | 1.96524104 |
| 146 | Abnormality of renin-angiotensin system (HP:0000847) | 1.96507963 |
| 147 | Abnormality of complement system (HP:0005339) | 1.95364193 |
| 148 | Hyponatremia (HP:0002902) | 1.94814051 |
| 149 | Multiple lipomas (HP:0001012) | 1.93815210 |
| 150 | Abnormality of the gastric mucosa (HP:0004295) | 1.93726638 |
| 151 | Abnormality of the nasal mucosa (HP:0000433) | 1.93387758 |
| 152 | Eczematoid dermatitis (HP:0000976) | 1.93313592 |
| 153 | Abnormal urine phosphate concentration (HP:0012599) | 1.91801671 |
| 154 | Facial shape deformation (HP:0011334) | 1.89745582 |
| 155 | Potter facies (HP:0002009) | 1.89745582 |
| 156 | Nephritis (HP:0000123) | 1.89517623 |
| 157 | Glomerulonephritis (HP:0000099) | 1.89026672 |
| 158 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.85324901 |
| 159 | Dicarboxylic aciduria (HP:0003215) | 1.84918641 |
| 160 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84918641 |
| 161 | Bone pain (HP:0002653) | 1.84006832 |
| 162 | Distal lower limb amyotrophy (HP:0008944) | 1.83467014 |
| 163 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83014345 |
| 164 | Vascular calcification (HP:0004934) | 1.82733319 |
| 165 | Gastrointestinal dysmotility (HP:0002579) | 1.81172666 |
| 166 | Abnormality of the costochondral junction (HP:0000919) | 1.79930957 |
| 167 | Metabolic acidosis (HP:0001942) | 1.77173673 |
| 168 | Hypolipoproteinemia (HP:0010981) | 1.76529301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB2 | 4.87370942 |
| 2 | ACVR1B | 4.18539042 |
| 3 | FRK | 3.18239935 |
| 4 | RIPK1 | 3.17849197 |
| 5 | MST1R | 3.01894572 |
| 6 | MST4 | 2.91315936 |
| 7 | LMTK2 | 2.65307584 |
| 8 | MAP2K2 | 2.42470094 |
| 9 | SIK1 | 2.16075399 |
| 10 | EPHA2 | 2.12124259 |
| 11 | TAOK3 | 11.7519247 |
| 12 | PRKG2 | 1.97053692 |
| 13 | GRK6 | 1.95663669 |
| 14 | TRIB3 | 1.83070616 |
| 15 | NME1 | 1.78880544 |
| 16 | PIK3CA | 1.76236354 |
| 17 | PTK6 | 1.75328691 |
| 18 | TAOK1 | 1.70659305 |
| 19 | MAP3K2 | 1.66841553 |
| 20 | IRAK3 | 1.57727169 |
| 21 | KSR2 | 1.51710213 |
| 22 | TESK1 | 1.38226450 |
| 23 | PTK2 | 1.30753015 |
| 24 | SMG1 | 1.28681527 |
| 25 | MAP3K9 | 1.25629011 |
| 26 | STK24 | 1.23782815 |
| 27 | MYLK | 1.16894138 |
| 28 | ICK | 1.08891511 |
| 29 | MET | 0.99313179 |
| 30 | MAP2K1 | 0.99171887 |
| 31 | PRPF4B | 0.98957063 |
| 32 | ARAF | 0.90439350 |
| 33 | MAP3K14 | 0.85922598 |
| 34 | MAP3K10 | 0.82779437 |
| 35 | EPHA3 | 0.81600306 |
| 36 | PAK4 | 0.81524658 |
| 37 | RIPK4 | 0.81492867 |
| 38 | MAPKAPK3 | 0.79731107 |
| 39 | PRKCI | 0.79095704 |
| 40 | ERBB2 | 0.78560929 |
| 41 | MAP3K13 | 0.78553930 |
| 42 | ERN1 | 0.76865390 |
| 43 | DDR2 | 0.76174899 |
| 44 | FER | 0.73381894 |
| 45 | MATK | 0.69639324 |
| 46 | STK10 | 0.64876057 |
| 47 | NME2 | 0.63598408 |
| 48 | TYK2 | 0.62293653 |
| 49 | MAP3K8 | 0.61864158 |
| 50 | MAP3K1 | 0.60722256 |
| 51 | MAP3K12 | 0.60520133 |
| 52 | MAP2K6 | 0.55555222 |
| 53 | EPHB1 | 0.53962381 |
| 54 | IRAK1 | 0.53202722 |
| 55 | MAP4K1 | 0.51262789 |
| 56 | ABL2 | 0.49097586 |
| 57 | PDGFRA | 0.47061529 |
| 58 | NEK6 | 0.46344170 |
| 59 | ILK | 0.46060957 |
| 60 | CAMK2D | 0.45620823 |
| 61 | AKT3 | 0.44460061 |
| 62 | ERBB4 | 0.44425951 |
| 63 | MAPK11 | 0.42377792 |
| 64 | TESK2 | 0.42168634 |
| 65 | WNK4 | 0.41207029 |
| 66 | PRKAA2 | 0.40532688 |
| 67 | TTK | 0.40127829 |
| 68 | FGFR3 | 0.39774641 |
| 69 | LIMK1 | 0.38975364 |
| 70 | RPS6KA2 | 0.38651360 |
| 71 | PAK1 | 0.37533904 |
| 72 | EPHA4 | 0.37163256 |
| 73 | SRC | 0.36652061 |
| 74 | ITK | 0.35901856 |
| 75 | NUAK1 | 0.34283242 |
| 76 | MAP3K7 | 0.33770751 |
| 77 | MAPK15 | 0.33117558 |
| 78 | CSF1R | 0.32761219 |
| 79 | MUSK | 0.31585133 |
| 80 | MAP3K3 | 0.31112932 |
| 81 | RET | 0.30215233 |
| 82 | DMPK | 0.30133407 |
| 83 | TBK1 | 0.29920397 |
| 84 | CAMK2B | 0.29805825 |
| 85 | IRAK4 | 0.29449624 |
| 86 | PDPK1 | 0.27875016 |
| 87 | BMX | 0.26686554 |
| 88 | CAMK2G | 0.26614686 |
| 89 | LRRK2 | 0.26072869 |
| 90 | OXSR1 | 0.25941626 |
| 91 | STK11 | 0.25725262 |
| 92 | PKN2 | 0.24613697 |
| 93 | PRKCZ | 0.24551964 |
| 94 | PTK2B | 0.23550167 |
| 95 | PRKCD | 0.23236806 |
| 96 | DYRK1B | 0.23118639 |
| 97 | PAK3 | 0.23090214 |
| 98 | PRKCA | 0.23050644 |
| 99 | CSK | 0.22933183 |
| 100 | IRAK2 | 0.21616156 |
| 101 | ZAP70 | 0.21216519 |
| 102 | PBK | 0.20714548 |
| 103 | RPS6KB2 | 0.20510284 |
| 104 | MELK | 0.20242692 |
| 105 | STK39 | 0.20019005 |
| 106 | PIM2 | 0.19290638 |
| 107 | SCYL2 | 0.18775232 |
| 108 | PRKCQ | 0.18731251 |
| 109 | MAP3K11 | 0.18610044 |
| 110 | FYN | 0.18601464 |
| 111 | LATS1 | 0.18200915 |
| 112 | CDC42BPA | 0.15959839 |
| 113 | CHUK | 0.15645511 |
| 114 | FGFR1 | 0.15029340 |
| 115 | GRK1 | 0.13725523 |
| 116 | SIK3 | 0.13671593 |
| 117 | PRKAA1 | 0.13029628 |
| 118 | PDK1 | 0.12514382 |
| 119 | PRKD2 | 0.12092571 |
| 120 | AKT2 | 0.11189812 |
| 121 | CDK6 | 0.10549241 |
| 122 | DAPK3 | 0.10432780 |
| 123 | KSR1 | 0.10142429 |
| 124 | PDK2 | 0.09783104 |
| 125 | FGFR4 | 0.09108162 |
| 126 | WNK3 | 0.09083301 |
| 127 | MAPKAPK2 | 0.07590307 |
| 128 | RPS6KA1 | 0.07444922 |
| 129 | EEF2K | 0.07076987 |
| 130 | PAK2 | 0.06858421 |
| 131 | PRKACG | 0.06702316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.08376890 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 4.26658785 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.18848838 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.87842911 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.81254832 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.75120070 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 2.54944133 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.29667416 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.26203568 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.24203319 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05716475 |
| 12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.98029284 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.94431127 |
| 14 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.82612607 |
| 15 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.82152992 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77904097 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.76029707 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.69865849 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69843556 |
| 20 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.62287174 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55246187 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.46173089 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41051845 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35655650 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.34169718 |
| 26 | Tight junction_Homo sapiens_hsa04530 | 1.26725169 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19868176 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15439594 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13062153 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12690911 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08148343 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07968057 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07354702 |
| 34 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.05861842 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05267155 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96432158 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93504910 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93501455 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90299169 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89867351 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88742111 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87958262 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85948155 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.84028049 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80615703 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.78631931 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78419803 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77781393 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.77727288 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73363385 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73158472 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 0.71782907 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70933513 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67358432 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67224712 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66377794 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65333974 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64364269 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61135906 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 0.60978586 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.60638057 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60216282 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58644446 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 0.58136639 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57937262 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56326612 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55974485 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.54086028 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53367325 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53180951 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52886193 |
| 72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52525392 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51644246 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48906844 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48778333 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48263418 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48181136 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.47469260 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47296189 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46931527 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45801509 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44792878 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42644923 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42251508 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.41941541 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41280449 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40076551 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.38984081 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.38434700 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38278794 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37664317 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37365134 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35773717 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35690145 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33951543 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33869851 |
| 97 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.33837337 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.32730671 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32232844 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31834819 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.31213948 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.29864601 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.29819123 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29805055 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29695654 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.28947235 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28699257 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25584108 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25238265 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24480914 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23480894 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22120711 |
| 113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.22055521 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20120808 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.19939260 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.19355046 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17820620 |
| 118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.17757835 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.17085235 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.16053211 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.15705609 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.15131273 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14378167 |
| 124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.13671600 |
| 125 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.12828967 |
| 126 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.10387879 |
| 127 | Leishmaniasis_Homo sapiens_hsa05140 | 0.07101486 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07042749 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06471114 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.02409804 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.02120514 |

